MedPath

A doubled-blind, crossover-RCT in T2DM to evaluate the hypoglycemic effect of P. indicus, M. charantia, P. vulgaris and A. paniculata

Phase 3
Conditions
type II DM (T2DM) patients
Registration Number
JPRN-UMIN000022442
Lead Sponsor
Semarang State University, Research Institute and Public Service (LP2M)
Brief Summary

FPG level decresed after extract, glibenclamide and combination treatment Two-hour PPG level decreased after three treatments as well

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Subjects that acquired complications or harm condition excluded from the study. Subjects did not meet the instruction excluded from the study as well.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change from baseline in Fasting Plasma Glucose & Two hours Postprandial Plasma Glucose after single week therapy of daily single dose 22mg/kgBW mixture extract Pterocarpus indicus 20%, Momordica charantia 10%, Phaseolus vulgaris 40% and Andrographis paniculata 30%
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath